Wellgistics Health Inc

Finanzen von Wellgistics Health Inc (WGRX)

$3.520

+1.052 (+29.89%)Zum Schluss

Profitabilität und Margen von WGRX

Evaluating the bottom line, DataMeds AI Inc maintains a gross margin of -11.97%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -385.72%, while the net margin is -496.46%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively WGRX converts its operational activities into shareholder value.

WGRX im Vergleich zur Peergroup

In the context of the broader market, WGRX competes directly with industry leaders such as JWEL and POM. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, WGRX's gross margin of -11.97% stands against JWEL's 8.16% and POM's 13.07%. Such benchmarking helps identify whether DataMeds AI Inc is trading at a premium or discount relative to its financial performance.

Finanzielle Entwicklung von Wellgistics Health Inc

No financial data available for analysis.

Financials

FY2026Q1
YoY:
-85.64%
1.56M
Total Revenue
FY2026Q1
YoY:
-80.81%
-6.02M
Operating Profit
FY2026Q1
YoY:
-76.13%
-7.74M
Net Income after Tax
FY2026Q1
YoY:
-88.15%
-3.70
EPS - Diluted
FY2026Q1
YoY:
+123.27%
-3.62M
Free Cash Flow
FY2026Q1
YoY:
+1085.15%
-11.97
Gross Profit Margin - %
FY2026Q1
-97.86
FCF Margin - %
FY2026Q1
YoY:
+66.30%
-496.46
Net Margin - %

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten